Novavax (NVAX)
(Delayed Data from NSDQ)
$12.52 USD
-0.04 (-0.32%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $12.54 +0.02 (0.16%) 4:22 PM ET
3-Hold of 5 3
D Value A Growth F Momentum C VGM
Brokerage Reports
0 items in cart
Novavax, Inc. [NVAX]
Reports for Purchase
Showing records 1 - 20 ( 308 total )
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Landmark Licensing Agreement Announced for COVID-19 Vaccine with Sanofi; Reiterate Buy and $19 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
FY23 Results: 4Q and Recent Results Make for a More Agile Organization
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V